Ads
related to: illumina inc- About ILUMYA®
Learn More To See If ILUMYA®
Could Be Right For You.
- Safety And Side Effects
Talk With Your Doctor About Safety
& See If ILUMYA® is Right For You.
- How ILUMYA® Works
Watch The Video To See
How ILUMYA® Works Differently.
- View Treatment Options
The Official ILUMYA® Patient Site
Talk To Your Dermatologist Today.
- ILUMYA® Patient Resources
Access the Patient Education Portal
and Learn More About ILUMYA®.
- ILUMYA® Patient Results
View Before & After Results from
Real Patients, with 5 Year Data.
- About ILUMYA®
Search results
Results From The WOW.Com Content Network
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Shares of Illumina were up 4% in extended trading. The gene sequencing machine maker founded Grail and spun it off in 2016, but re-acquired it in 2021 for $7.1 billion to enter the cancer early ...
Illumina expects full-year adjusted profit per share to be between $0.75 and $0.90, compared with its prior forecast of $1.25 to $1.50. The outlook reflects a tax expense impact of about $75 million.
Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing ...
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms. [3] Grail was spun-out from Illumina on June 24, 2024.
SynthLabs, formerly Illumina, Symantec, IMLogic, Microsoft, Flash Francis Aurelio deSouza ( / ˈ d ʌ s uː z ɑː / ; born December 2, 1970) is an American entrepreneur and business executive. He is co-founder of SynthLabs, and a member of the Board of Directors of Deel Inc. [ 1 ]
Illumina has also reaffirmed its forecast for the first quarter and full-year 2024. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 ...
Rastetter serves as an adviser to Illumina Ventures, which focuses its investments in start-up companies driven by genomics and next generation sequencing technologies. [35] [36] Rastetter served on the board of directors of Illumina, Inc. from 1998 to 2016, and as the non-executive chair of the Board of Directors of Illumina, Inc. from 2005 to ...
Ad
related to: illumina inc